ProfileGDS4284 / 1561849_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 10% 6% 3% 10% 17% 15% 13% 5% 12% 7% 16% 8% 22% 9% 22% 16% 12% 20% 14% 28% 44% 14% 29% 27% 23% 30% 24% 22% 10% 29% 13% 4% 7% 3% 13% 3% 16% 12% 28% 33% 2% 7% 8% 35% 15% 18% 22% 35% 64% 18% 39% 5% 36% 18% 26% 25% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control15.735810
GSM687648Patient 402 control10.08696
GSM687653Patient 403 control6.354313
GSM687658Patient 404 control17.431110
GSM687663Patient 411 control35.380417
GSM687668Patient 422 control25.213715
GSM687673Patient 424 control25.339513
GSM687678Patient 425 control10.85215
GSM687683Patient 427 control22.430212
GSM687688Patient 428 control11.4587
GSM687695Patient 441 control53.584316
GSM687699Patient 443 control17.56378
GSM687704Patient 444 control46.651322
GSM687707Patient 448 control19.17139
GSM687712Patient 449 control44.147922
GSM687719Patient 450 control35.674116
GSM687724Patient 451 control24.157612
GSM687728Patient 452 control45.29520
GSM687646Patient 401 treated 24h23.632614
GSM687649Patient 402 treated 24h62.689628
GSM687665Patient 411 treated 24h181.9244
GSM687651Patient 402 treated 4 weeks24.923614
GSM687667Patient 411 treated 4 weeks74.893629
GSM687670Patient 422 treated 24h71.300427
GSM687671Patient 422 treated 4 weeks48.77223
GSM687654Patient 403 treated 24h71.263730
GSM687675Patient 424 treated 24h61.377124
GSM687685Patient 427 treated 24h47.341222
GSM687656Patient 403 treated 4 weeks14.065610
GSM687677Patient 424 treated 4 weeks74.008729
GSM687687Patient 427 treated 4 weeks19.630513
GSM687692Patient 428 treated 4h8.792224
GSM687716Patient 449 treated 4h14.46427
GSM687722Patient 450 treated 4h9.4343
GSM687680Patient 425 treated 24h23.451513
GSM687690Patient 428 treated 24h6.99143
GSM687700Patient 443 treated 24h46.303116
GSM687705Patient 444 treated 24h19.460112
GSM687714Patient 449 treated 24h66.065328
GSM687721Patient 450 treated 24h112.27733
GSM687682Patient 425 treated 4 weeks5.387442
GSM687694Patient 428 treated 4 weeks10.88257
GSM687702Patient 443 treated 4 weeks16.31218
GSM687718Patient 449 treated 4 weeks104.88435
GSM687723Patient 450 treated 4 weeks27.588815
GSM687661Patient 404 treated 4h38.086518
GSM687710Patient 448 treated 4h46.551122
GSM687726Patient 451 treated 4h122.80835
GSM687730Patient 452 treated 4h661.14264
GSM687660Patient 404 treated 24h48.902218
GSM687697Patient 441 treated 24h171.15439
GSM687709Patient 448 treated 24h10.80555
GSM687725Patient 451 treated 24h139.9436
GSM687729Patient 452 treated 24h50.210218
GSM687727Patient 451 treated 4 weeks75.437626
GSM687731Patient 452 treated 4 weeks66.469125